Zachry Acquires Ambitech Engineering

(c) Lichtmeister/Shutterstock
(c) Lichtmeister/Shutterstock

US engineering and construction group Zachry has acquired rival firm Ambitech Engineering for an undisclosed sum. Zachry said the acquisition adds extensive resources, capabilities and market reach.

Ambitech, headquartered in Chicago, Illinois, has 750 employees in multiple locations across the US as well as in India, the Philippines and the Middle East. Its primary industry sectors include refining, petrochemicals, food and beverage, pharmaceuticals, biotechnology and consumer products.

John Zachry, chairman and CEO of Zachry, said the company is always looking for opportunities to grow and improve its capabilities. “To acquire a high-performing and well-regarded company will be a game-changer for us,” he said, adding that the Ambitech team further enhances Zachry’s ability to provide full-service support to its principal businesses across North America, including engineering, construction, maintenance, turnarounds and specialty services.

Headquartered in San Antonio, Texas, Zachry operates 35 offices with over 22,000 employees working in more than 400 locations across North America. The company has worked with major petrochemical companies such as BASF, Ineos, ExxonMobil, Chevron Phillips Chemical, among others.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.